Serum level of fibroblast growth factor 21 predicts long-term prognosis in patients with both diabetes mellitus and coronary artery calcification
Author(s) -
Feng Gan,
Jiafang Huang,
Tianran Dai,
Maorong Li,
Jinghua Liu
Publication year - 2020
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm.2020.03.28
Subject(s) - medicine , diabetes mellitus , fibroblast growth factor 23 , calcification , artery , fibroblast growth factor , cardiology , fgf21 , coronary artery disease , endocrinology , calcium , parathyroid hormone , receptor
This study aimed to investigate the relationship between serum level of fibroblast growth factor 21 (FGF-21) and long-term prognosis in patients with both diabetes mellitus (DM) and coronary artery calcification (CAC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom